A vaccine that fights pneumonia and other diseases could save the lives of thousands of children each year in Latin America, but high costs have kept it from those who need it, a researcher told a congress of health professionals Thursday.
NEW CANAAN, CT, January 30, 2006—The Board of Trustees of the Albert B. Sabin Vaccine Institute (Sabin) announced personnel changes made to strengthen the Institute’s efforts in the area of cancer vaccines. At a January 12 meeting in New York, the Board elected Axel Hoos, MD, PhD, as a trustee and approved the appointment of Robert Allen, MD, as vice president for cancer programs.
WASHINGTON, D.C., Sept. 7, 2005 – The Albert B. Sabin Vaccine Institute (Sabin), a leader in promoting the development and use of safe and effective vaccines to prevent disease, announced receipt of a grant of $150,000 from the Bill & Melinda Gates Foundation for the sponsorship of a vaccine policy colloquium to be held at Cold Spring Harbor, Long Island, New York, October 19-21, 2005.
NEW CANAAN, CT, JUNE 29, 2005 —The Sabin Vaccine Institute will recognize extraordinary contributors to disease research and healthcare innovations at its black-tie gala beginning at 6:30 p.m. on June 29, 2005 at the University Club in New York City.
NEW CANAAN, CT— Albert Z. Kapikian, MD, physician, medical pioneer and viral diseases researcher, received the prestigious Albert B. Sabin Gold Medal at a ceremony on May 10, 2005. Kapikian is the 13th recipient of this recognition, awarded annually by the Sabin Vaccine Institute to honor achievements by vaccinologists and infectious disease experts.
July 7, 2004